ACC: Semaglutide Beneficial in Patients With T2DM and Peripheral Artery Disease
Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes
Zepbound Now Available Through Hims & Hers
FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia
Subcutaneous injection cuts the amount of the protein antithrombin, leading to an increase in thrombin
Prevalence of Prescription Stimulant Misuse High in U.S. Adults
Higher prevalence ratios for misuse, prescription stimulant use disorder seen for those using amphetamines versus methylphenidate
Common Photosensitizing Drugs Increase Skin Cancer Risk
Estrogen treatment increased the risk for all investigated skin cancers
Guideline Adherence Suboptimal for Chlamydia, Gonorrhea Treatment
14.0 percent of chlamydia cases and 38.7 percent of gonorrhea cases receive treatment with recommended antibiotic
Evidence Supports Continuing Buprenorphine for Acute Pain in Those With Opioid Use Disorder
Continuing use of buprenorphine during acute pain episodes may be associated with similar, improved pain outcomes versus discontinuation
FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors
Patients treated with cabozantinib survived significantly longer with no worsening of their disease compared with patients who received placebo
Top FDA Vaccine Official Quits, Warns of Vaccine Misinformation
